Freenome is a healthcare technology company that provides non-invasive disease screenings to proactively detect cancer and other diseases at their most manageable stages. Freenome’s mission is to reinvent disease management through early detection and intervention. The company works to make cancer screening and diagnostics as accurate and accessible as possible, through a fusion of machine learning, biology and computer science. Major investors in Freenome include Andreessen Horowitz and Charles River Associates, among various others.


We work with Freenome in a search capacity, leveraging our network and healthcare industry expertise to find and place the best executives on their leadership team. Our work includes a search for their Chief Commercial Officer.